Literature DB >> 11550310

The blood-brain barrier in primary CNS lymphomas: ultrastructural evidence of endothelial cell death.

P P Molnár1, B P O'Neill, B W Scheithauer, D R Groothuis.   

Abstract

The vasculature of 24 primary CNS B-cell lymphomas that were not related to acquired immunodeficiency syndrome was systematically studied by electron microscopy. Seven low-grade astrocytic tumors were included for comparison. Classical electron microscopy features of apoptosis were found in lymphoma cells of 21 of 22 subjects. Capillaries of gliomas and lymphomas showed changes reported previously: variability of endothelial cell (EC)-thickness and number, basal lamina thickness and duplication, and fenestrations. Primary CNS B-cell lymphoma ECs showed two distinctive populations of electron-dense and electron-lucent cells. The electron-dense ECs occurred in 38% of all capillaries, with changes consisting of chromatin condensation in bizarre and contracted nuclei, cytoplasmic shrinkage with markedly increased electron density, and dilatation of the endoplasmic reticulum. We interpreted these changes as indicative of apoptosis. Cell death eventually resulted in complete disintegration of the endothelium with frank discontinuities of the EC component of the blood-tumor barrier in capillaries and postcapillary venules. Another population of ECs had increased cell volume, conspicuous cytoplasmic electron lucency, dispersed organelles, scattered vesicles, and apical stress fibers. We interpreted these changes as indicative of cellular regeneration. Individual apoptotic ECs often lay next to normal or regenerating ECs. Neither type of EC change was observed in gliomas, which also lacked perivascular neoplastic lymphocytic cuffing. We believe that these populations of ECs, which have not been described in other disorders affecting the blood-brain barrier, may be induced by cytokines released from necrotic and/or apoptotic tumor lymphocytes and may explain the unusual imaging characteristics of primary CNS B-cell lymphomas treated with corticosteroids.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11550310      PMCID: PMC1920754          DOI: 10.1093/neuonc/1.2.89

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  15 in total

Review 1.  Permeability imaging in pediatric brain tumors.

Authors:  Sandi Lam; Yimo Lin; Peter C Warnke
Journal:  Transl Pediatr       Date:  2014-07

2.  Single-agent rituximab for primary CNS lymphoma during pregnancy as a bridge to definitive management.

Authors:  Brian L Burnette; Mark A Jentoft; Luis F Porrata; Thomas G Boyce; Thomas E Witzig
Journal:  J Clin Oncol       Date:  2014-01-06       Impact factor: 44.544

3.  Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.

Authors:  Ji Ye Lee; Atle Bjørnerud; Ji Eun Park; Bo Eun Lee; Joo Hyun Kim; Ho Sung Kim
Journal:  Eur Radiol       Date:  2019-03-15       Impact factor: 5.315

4.  Role of ceramide during cisplatin-induced apoptosis in C6 glioma cells.

Authors:  S Noda; S Yoshimura; M Sawada; T Naganawa; T Iwama; S Nakashima; N Sakai
Journal:  J Neurooncol       Date:  2001-03       Impact factor: 4.130

5.  Differentiation between glioblastoma and primary CNS lymphoma: application of DCE-MRI parameters based on arterial input function obtained from DSC-MRI.

Authors:  Koung Mi Kang; Seung Hong Choi; Park Chul-Kee; Tae Min Kim; Sung-Hye Park; Joo Ho Lee; Soon-Tae Lee; Inpyeong Hwang; Roh-Eul Yoo; Tae Jin Yun; Ji-Hoon Kim; Chul-Ho Sohn
Journal:  Eur Radiol       Date:  2021-05-18       Impact factor: 5.315

6.  Hemorrhage and VEGF expression in a case of primary CNS lymphoma.

Authors:  James Rubenstein; Nancy Fischbein; Ken Aldape; Eric Burton; Marc Shuman
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

7.  Differentiation of primary central nervous system lymphomas and glioblastomas: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging without and with contrast-leakage correction.

Authors:  C H Toh; K-C Wei; C-N Chang; S-H Ng; H-F Wong
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-24       Impact factor: 3.825

8.  Evaluation of microvascular permeability with dynamic contrast-enhanced MRI for the differentiation of primary CNS lymphoma and glioblastoma: radiologic-pathologic correlation.

Authors:  P Kickingereder; F Sahm; B Wiestler; M Roethke; S Heiland; H-P Schlemmer; W Wick; A von Deimling; M Bendszus; A Radbruch
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-10       Impact factor: 3.825

9.  MR perfusion in and around the contrast-enhancement of primary CNS lymphomas.

Authors:  Stella Blasel; Alina Jurcoane; Oliver Bähr; Lutz Weise; Patrick N Harter; Elke Hattingen
Journal:  J Neurooncol       Date:  2013-05-22       Impact factor: 4.130

10.  Diagnostic Accuracy of T1-Weighted Dynamic Contrast-Enhanced-MRI and DWI-ADC for Differentiation of Glioblastoma and Primary CNS Lymphoma.

Authors:  X Lin; M Lee; O Buck; K M Woo; Z Zhang; V Hatzoglou; A Omuro; J Arevalo-Perez; A A Thomas; J Huse; K Peck; A I Holodny; R J Young
Journal:  AJNR Am J Neuroradiol       Date:  2016-12-08       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.